Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-03

Clinical Trial Update: Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous alveolar bone marrow mesenchymal stem cells for reconstruction of infrabony periodontal defects in chronic period…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous alveolar bone marrow mesenchymal stem cells (autologous alveolar bone marrow mesenchymal stem cells)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Chronic Periodontitis | Phase 1, Phase 2 | Status: COMPLETED